McWin Partners
VC Fund
Praha, Czech Republic
McWin Partners is a VC fund in Praha focused on Biotechnology and AgTech. McWin is a private investment firm that focuses on Food Tech, Life Science, Clean Tech, Mobility Space Tech, Digitalization, and Fintech.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries McWin Partners invests in
Stages McWin Partners invests in
Countries McWin Partners invests in
Round sizes
Round size
- Series B
- $67M–$150M
- Series C
- $42M–$175M
- Series D
- $55M–$106M
Investment Focus
Industry
- Biotechnology 3 (25%)
- AgTech 2 (17%)
- Farming 2 (17%)
- Robotics 2 (17%)
- Agriculture 2 (17%)
Stage
- Series B 2 (17%)
- Series C 2 (17%)
- Series D 2 (17%)
- Seed 1 (8%)
- Series A 1 (8%)
Country
- United States 4 (33%)
- Ireland 2 (17%)
- France 1 (8%)
- Switzerland 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Clara Foods™ is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animalagriculture with a more sustainable, kinder and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them. | $55M / Series D / Nov 04, 2025 | |
|
|
Clara Foods™ is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animalagriculture with a more sustainable, kinder and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them. | $55M / Series D / Nov 04, 2025 | |
|
|
ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs. | $105.7M / Series D / Oct 13, 2025 | |
|
|
Nuritas is revolutionising the discovery of novel, natural and scientifically proven active ingredients that can manage and improve human health. The company’s disruptive computational approach to discovery uses artificial intelligence and genomics to, for the first time ever, rapidly and efficiently predict and then provide access to the mosthealth-benefiting components hidden within food, called bioactive peptides. | $42M / Series C / Dec 20, 2024 | |
|
|
Nuritas is revolutionising the discovery of novel, natural and scientifically proven active ingredients that can manage and improve human health. The company’s disruptive computational approach to discovery uses artificial intelligence and genomics to, for the first time ever, rapidly and efficiently predict and then provide access to the mosthealth-benefiting components hidden within food, called bioactive peptides. | $42M / Series C / Dec 20, 2024 | |
|
|
Oishii Farm provides indoor vertical farming technology. Oishii sells via supermarkets, offering a container of between eight and 11 strawberries for $50 per package. Hiroki Koga and Brendan Somerville started the company in 2017. | $150M / Series B / Feb 27, 2024 | |
|
|
Clever Carnivore is a cell-cultured meat startup that uses stem cell biology, recombinant protein, and bioengineering to create cost-effective lab grown meats. With the company's high-efficiency model, cruelty-free, environmentally friendly, and cost-competitive technology it aims to produce sausage, burgers, and chicken nuggets. | $7M / Seed / Dec 04, 2023 | |
|
|
Exergyn is a clean-tech company that develops solid state HVAC technology (heat pumps and air conditioning). The company creates a component that it claims can be inserted into a variety of existing energy products, replacing environmentally hazardous refrigerants. Exergyn was founded in 2012 and is headquartered in Dublin 11, Dublin. | $34M / Series A / Jan 21, 2022 | |
|
|
Clara Foods™ is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animalagriculture with a more sustainable, kinder and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them. | $175M / Series C / Dec 07, 2021 | |
|
|
Clara Foods™ is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animalagriculture with a more sustainable, kinder and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them. | $175M / Series C / Dec 07, 2021 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does McWin Partners invest in?
McWin Partners invests primarily in Biotechnology, AgTech and Farming startups, most often at Series B and Series C stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is McWin Partners's check size?
McWin Partners typically joins rounds of $67M–$150M at Series B, $42M–$175M at Series C and $55M–$106M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds McWin Partners participates in.
When did McWin Partners last invest?
The most recent investment recorded for McWin Partners closed in Nov 2025. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!